AI-generated summary
The authors randomized 70 head and neck cancer patients to one of two low-level laser settings during radiotherapy and compared oral mucositis and pain. The higher-dose group reached grade II mucositis later and reported lower pain, and the authors conclude the therapy was effective in controlling mucositis intensity and pain.
- Participants
- 70
- Who or what was studied
- Patients with malignant neoplasms in the oral cavity or oropharynx receiving radiotherapy for head and neck cancer
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not describe a control group without laser, and it does not report the full statistical methods or adverse events.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, GRADE, Visual analogue scale, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.